Generic name of Darbepoetin is Sindilizumab Injection, which is mainly used to treat patients with Hodgkin’s lymphoma, non-squamous non-small cell lung cancer and metastatic hepatocellular carcinoma. Sindilizumab Injection is an immunotherapeutic drug that was started to be used in Hodgkin’s Lymphoma, which is mainly used to treat the disease by promoting apoptosis of tumor cells. This drug can be combined with chemotherapeutic drugs such as pemetrexed and platinum for the first-line treatment of non-squamous non-small cell lung cancer, which can further improve the prognosis of patients. It is also used in combination with bevacizumab injection for the treatment of patients with unresectable or metastatic hepatocellular carcinoma who have not received prior systemic therapy. For other advanced malignant tumors, the efficacy of the application of Sindilizumab Injection is not exact, and the use of the drug needs to follow the doctor’s instructions.